Edition:
United States

GW Pharmaceuticals PLC (GWPH.O)

GWPH.O on Consolidated Issue listed on NASDAQ Global Market

184.00USD
21 May 2019
Change (% chg)

$5.12 (+2.86%)
Prev Close
$178.88
Open
$180.00
Day's High
$186.27
Day's Low
$179.27
Volume
571,269
Avg. Vol
473,968
52-wk High
$196.00
52-wk Low
$90.14

About

GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers... (more)

Overall

Beta: 2.69
Market Cap(Mil.): $5,494.98
Shares Outstanding(Mil.): 2.56
Dividend: --
Yield (%): --

Financials

  GWPH.O Industry Sector
P/E (TTM): -- 97.03 53.45
EPS (TTM): -8.90 -- --
ROI: -41.83 7.44 11.71
ROE: -43.66 7.90 16.35

Earnings vs. Estimates